Citation tools
"Correction to “A Novel Aminotetralin-Type Serotonin (5-HT) 2C Receptor-Specific Agonist and 5-HT2A Competitive Antagonist/5-HT2B Inverse Agonist with Preclinical Efficacy for Psychoses”." Journal of Pharmacology and Experimental Therapeutics
349.3
(2014):
533.
Web. 19 April. 2024.